What does Indivior Pharmaceuticals, Inc. do?
Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat…
What is Indivior Pharmaceuticals, Inc.'s P/E and P/B ratio?
Indivior Pharmaceuticals, Inc. has a P/E ratio of 12.7 and a P/B ratio of -20.15.
What is Indivior Pharmaceuticals, Inc.'s debt-to-equity ratio?
Indivior Pharmaceuticals, Inc. has a debt-to-equity ratio of -3.55.
How much does Indivior Pharmaceuticals, Inc. owe compared with what it owns?
Indivior Pharmaceuticals, Inc. owes $1.17 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Indivior Pharmaceuticals, Inc.'s Positivity rank?
Indivior Pharmaceuticals, Inc. is ranked #6,628 of 6,774 companies globally and #3,868 of 4,000 in United States on PositoAI, with a Positivity Score of -31,685.
Does Indivior Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Indivior Pharmaceuticals, Inc..
Where can I read the latest news about Indivior Pharmaceuticals, Inc.?
Recent headlines about Indivior Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Indivior Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Indivior Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.